TGFB1 and pulmonary fibrosis: In conclusion, we provided further evidence of the antifibrotic effects of GED-0507 by demonstrating the compound’s ability to modulate several fibrosis pathways in BLM-induced pulmonary fibrosis and in TGFβ-exposed lung epithelial cells and fibroblasts.